- Home
- AEHL vs COCP Comparison
AEHL vs COCP Comparison
Compare AEHL & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- COCP
- Stock Information
- Founded
- AEHL 1993
- COCP 2006
- Country
- AEHL China
- COCP United States
- Employees
- AEHL N/A
- COCP N/A
- Industry
- AEHL Building Materials
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- AEHL Industrials
- COCP Health Care
- Exchange
- AEHL Nasdaq
- COCP Nasdaq
- Market Cap
- AEHL 17.3M
- COCP 15.4M
- IPO Year
- AEHL 2007
- COCP N/A
- Fundamental
- Price
- AEHL $1.67
- COCP $1.07
- Analyst Decision
- AEHL
- COCP Strong Buy
- Analyst Count
- AEHL 0
- COCP 1
- Target Price
- AEHL N/A
- COCP $6.00
- AVG Volume (30 Days)
- AEHL 414.9K
- COCP 197.1K
- Earning Date
- AEHL 12-26-2025
- COCP 11-14-2025
- Dividend Yield
- AEHL N/A
- COCP N/A
- EPS Growth
- AEHL N/A
- COCP N/A
- EPS
- AEHL N/A
- COCP N/A
- Revenue
- AEHL $98,773,000.00
- COCP N/A
- Revenue This Year
- AEHL N/A
- COCP N/A
- Revenue Next Year
- AEHL N/A
- COCP N/A
- P/E Ratio
- AEHL N/A
- COCP N/A
- Revenue Growth
- AEHL 36.99
- COCP N/A
- 52 Week Low
- AEHL $1.40
- COCP $1.00
- 52 Week High
- AEHL $13.06
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- AEHL 31.63
- COCP 43.45
- Support Level
- AEHL $1.78
- COCP $1.06
- Resistance Level
- AEHL $2.19
- COCP $1.15
- Average True Range (ATR)
- AEHL 0.32
- COCP 0.07
- MACD
- AEHL -0.10
- COCP 0.01
- Stochastic Oscillator
- AEHL 15.43
- COCP 23.54
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).